Skip to content
DraconiticResearch
Search Sources API
194,161 studies31 sourcesUpdated 12 min ago
PreprintCC BY-NC-NDbioRxiv

Aquaporin-9 and aquaporin-10 but not aquaporin-3 confer susceptibility to dimethylarsinic acid genotoxicity in human cells

  1. 1Institute of Biosciences and Technology, Texas A & M Health Science Center, Houston, TX, USA

Abstract

Human metabolism converts inorganic arsenic to the pentavalent methylated species MMA(V) and DMA(V), the forms most people excrete, and the forms long read as the end of a detoxification pathway. Whether a transporter sets how much of these metabolites reaches the genome has not been tested in a mammalian cell. We expressed human AQP3, AQP7, AQP9 or AQP10 in HEK293T and MRC5-SV40 cells and measured gamma-H2AX by flow cytometry across dose series of As(V), MMA(V) and DMA(V), pairing every aquaporin with a GFP-Tubulin control and an untransfected mock acquired in the same replicate. As(V) was inactive in HEK293T cells and only weakly active in MRC5-SV40 cells to 20 micromolar, and both methylated species damaged DNA only in the millimolar range, DMA(V) being the more potent of the two in both cell lines. Against that weak baseline, AQP9 and AQP10 raised DMA(V)-induced gamma-H2AX in HEK293T cells by roughly 17 percentage points over the matched control, more than doubling the damage the same exposure produced in control cells, whereas AQP3 and AQP7 changed it not at all. AQP9 alone remained active with MMA(V). The ranking held in MRC5-SV40 fibroblasts at one-sixth the size, and within single wells the damage rose with the amount of AQP9 a cell carried while the control was flat. Aquaglyceroporins therefore discriminate among arsenic species, and AQP9 and AQP10 turn a weakly genotoxic metabolite into a substantially more genotoxic one.

Related

  1. Cytotoxicity and genotoxicity of cyphenothrin active ingredient compared with its microencapsulated commercial formulation in human cell lines: an in vitro study
    Moustafa Sherif, Moustafa Sherif, Abderrahim Nemmar +2
    Frontiers in ToxicologyPeer-reviewedCC BYFull textOncologyDOAJ
  2. Genomic Epidemiology and Antimicrobial Susceptibility of Human Brucellosis — Shenzhen City, Guangdong Province, China, 2005–2024
    Li Yuan, Cong Niu, Shiting Chen +5
    China CDC weeklyPeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
  3. Research Progress on Genotoxicity and Molecular Mechanisms of Environmental Endocrine Disruptors
    Junmei Xia, Jiaying Li, Yingxin Yang +3
    ToxicsPeer-reviewedCC BYFull textPharmacology & toxicologyEurope PMC
  4. Saccharin-Enabled Oral Formulation, Biopharmaceutics and Early Genotoxicity Assessment of the PPARγ Antagonist T0070907
    Charlotte Devant, François Xavier Legrand, Maria Eugenia Marques da Costa +5
    PharmaceuticsPeer-reviewedCC BYFull textGeneral biologyPharmacology & toxicologyHALEurope PMC
  5. SA-β-Gal stratification reveals senescence-associated heterogeneity and differential cell death susceptibility in human CD8 effector T cells
    Luis Garza-Martínez, Mark Apadeer, Nica Mariz Aquino +5
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textPhysiologyCrossrefDOAJ
BibTeX
@misc{yin2026aquaporin9,
  title = {{Aquaporin-9 and aquaporin-10 but not aquaporin-3 confer susceptibility to dimethylarsinic acid genotoxicity in human cells}},
  author = {S. Yin and B. Feng and M. Vaziripour and J. Xia},
  howpublished = {bioRxiv},
  year = {2026},
  month = sep,
  doi = {10.64898/2026.09.20.752519},
  url = {https://www.biorxiv.org/content/10.64898/2026.09.20.752519v1},
  note = {CC BY-NC-ND},
}
RIS
TY  - UNPB
TI  - Aquaporin-9 and aquaporin-10 but not aquaporin-3 confer susceptibility to dimethylarsinic acid genotoxicity in human cells
AU  - S. Yin
AU  - B. Feng
AU  - M. Vaziripour
AU  - J. Xia
PY  - 2026
DA  - 2026/09/20
PB  - bioRxiv
DO  - 10.64898/2026.09.20.752519
UR  - https://www.biorxiv.org/content/10.64898/2026.09.20.752519v1
AB  - Human metabolism converts inorganic arsenic to the pentavalent methylated species MMA(V) and DMA(V), the forms most people excrete, and the forms long read as the end of a detoxification pathway. Whether a transporter sets how much of these metabolites reaches the genome has not been tested in a mammalian cell. We expressed human AQP3, AQP7, AQP9 or AQP10 in HEK293T and MRC5-SV40 cells and measured gamma-H2AX by flow cytometry across dose series of As(V), MMA(V) and DMA(V), pairing every aquaporin with a GFP-Tubulin control and an untransfected mock acquired in the same replicate. As(V) was inactive in HEK293T cells and only weakly active in MRC5-SV40 cells to 20 micromolar, and both methylated species damaged DNA only in the millimolar range, DMA(V) being the more potent of the two in both cell lines. Against that weak baseline, AQP9 and AQP10 raised DMA(V)-induced gamma-H2AX in HEK293T cells by roughly 17 percentage points over the matched control, more than doubling the damage the same exposure produced in control cells, whereas AQP3 and AQP7 changed it not at all. AQP9 alone remained active with MMA(V). The ranking held in MRC5-SV40 fibroblasts at one-sixth the size, and within single wells the damage rose with the amount of AQP9 a cell carried while the control was flat. Aquaglyceroporins therefore discriminate among arsenic species, and AQP9 and AQP10 turn a weakly genotoxic metabolite into a substantially more genotoxic one.
ER  -